JAK2 and myeloproliferative neoplasm: For example, while the JAK2 V617F mutation is the most common, particularly in MPN, a gain of function mutation in exon 12 of JAK2 is characteristic for polycythemia vera (PV) and is not commonly seen in primary myelofibrosis (PMF) or ET [7,8].